Welcome to our dedicated page for Astrotech SEC filings (Ticker: ASTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Astrotech Corporation (ASTC) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Astrotech is a Nasdaq-listed mass spectrometry company that operates through wholly owned subsidiaries focused on explosives and narcotics trace detection, security screening, environmental testing, industrial process control, agriculture process analyzers, and breath analysis platforms for volatile organic compounds. Its filings offer detailed insight into how these activities affect the company’s financial condition, governance, and capital structure.
Investors can review Astrotech’s periodic reports, such as its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, for information on revenue, operating expenses, research and development spending, liquidity, and risk factors associated with its mass spectrometry and gas chromatography businesses. Current Reports on Form 8-K document material events, including financial results announcements, executive appointments and departures, adoption of a transaction bonus plan tied to potential qualifying transactions, amendments to a Rights Agreement affecting security holder rights, and the Board of Directors’ decision to initiate a review of strategic alternatives.
Proxy materials, such as the definitive proxy statement on Schedule 14A, describe Astrotech’s board composition, director elections, executive and director compensation, and proposals submitted to stockholders at the annual meeting. These documents also outline the matters on which stockholders are asked to vote, such as the ratification of the independent registered public accounting firm.
On Stock Titan, AI-powered tools can assist readers by summarizing lengthy filings, highlighting key items from Astrotech’s 10-K and 10-Q reports, and surfacing notable 8-K disclosures related to governance, compensation arrangements, or strategic reviews. This helps users quickly understand the implications of new filings, follow changes in Astrotech’s corporate structure and capital markets activity, and place individual documents in the broader context of the company’s mass spectrometry-focused business model.
Astrotech Corporation (ASTC) filed its definitive proxy for the 2025 annual meeting. The meeting is set for December 12, 2025 at 9:00 a.m. CST at 1817 West Braker Lane, Suite 400, Austin, Texas. Stockholders will vote to elect six director nominees to serve until the 2026 annual meeting and to ratify RBSM LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
The record date is October 16, 2025. Shares outstanding were 1,769,269 as of October 16, 2025, including 82,500 shares of restricted stock with voting rights, with one vote per share. The Board recommends voting for all nominees—Thomas B. Pickens III, Tom Wilkinson, Bob McFarland, Eric Stober, John Halinski, and Charles Winn—and for auditor ratification. Voting is available by mail, phone (1-888-457-2959), or online (www.proxyvoting.com/ASTC). The proxy also details board committee structures, director independence, executive compensation, and one related-party transaction disclosed under company policy.
Astrotech Corporation announced that Jennifer Canas resigned as Chief Financial Officer, Treasurer and Secretary, effective immediately on October 17, 2025. The company reported her resignation under Item 5.02 of the Exchange Act.
Astrotech intends to negotiate a separation agreement with Ms. Canas that would outline certain separation benefits and include restrictive covenants in favor of the company. No additional management changes or financial details are included in this report.
ASTROTECH Corp (ASTC) reported insider dispositions by director Leonard Braden Michael on 10/03/2025. The filing shows the sale of 220,410 shares at an average price of $7.1305 and an additional 9,166 shares at $5.83, reducing the reporting person’s beneficial ownership to 0 shares. The filer clarifies that the shares sold included holdings of BML Investment Partners, L.P., for which Mr. Leonard exercises investment and voting control but disclaims direct beneficial ownership except for pecuniary interest. The form is signed and dated 10/07/2025.
Astrotech Corporation (ASTC) had a reporting holder fully exit its position. BML Investment Partners, L.P. and its related person, Braden M. Leonard, reported that they no longer beneficially own any common shares after selling a total of 229,576 shares on 10/03/2025. The filing states BML Investment Partners sold 220,410 shares at a weighted average price of $7.1305 and Mr. Leonard sold 9,166 shares at $5.83. The original acquisition used approximately $3.77 million of working capital. The report updates ownership to 0 shares (0%) and discloses organizational relationships linking Mr. Leonard, BML Capital Management, LLC and BML Investment Partners.
Astrotech Corp (ASTC) operates technologies based on the Astrotech Mass Spectrometer Technology and subsidiaries that develop explosive and narcotic trace detectors for security and industrial markets. The filing discloses approximately $1.0 million in revenue for the most recent year, with prior-year revenue of about $1.7 million driven largely by three customers. The company reported operating losses of $13.8 million in fiscal 2025 and $11.7 million in fiscal 2024. Shares outstanding at June 30, 2025 were 1,758,953 after a 1-for-30 reverse stock split applied retroactively. Lease commitments include a new Austin facility with contractual base rent of about $3.0 million (less a $317.3 thousand tenant allowance). The company holds net operating loss carryforwards (approximately $37.8 million and indefinite-lives of ~$60.2 million for federal tax purposes, with limited realizable benefit), reports no material allowance for doubtful accounts, and had inventory reserves of $346 thousand at June 30, 2025. Significant customer concentration and ongoing operating losses are disclosed.
Astrotech Corporation filed a current report stating that it has issued a press release announcing its results of operations for the quarter and year ended June 30, 2025.
The press release, dated September 25, 2025, is furnished as Exhibit 99.1 and is incorporated by reference in this report. The company notes that the information provided under this item, including Exhibit 99.1, is being furnished rather than filed, which means it is not automatically subject to certain Exchange Act liabilities or incorporated into other securities offerings unless specifically referenced.
Nihanth Badugu, Chief Operating Officer of Astrotech Corporation (ASTC), filed an initial Form 3 reporting ownership of employee stock options. The filing lists two option grants: an option covering 1,800 common shares with an $11.87 exercise price (expiration shown 08/07/2033) and an option covering 840 common shares with an $11.51 exercise price (expiration shown 08/28/2034). The first grant vests in three equal annual installments beginning on the first anniversary of the grant (600 shares vested on 08/07/2024 and 600 shares vested on 08/07/2025). The second grant also vests in three equal annual installments (280 shares vested on 08/28/2025). The Form is signed and dated 08/28/2025.
Astrotech Corporation announced the appointment of Nihanth Badugu as Chief Operating Officer, effective August 13, 2025. Mr. Badugu, age 37, has served as the company’s Director of Program Management since August 2023 and previously held program and NPI management roles at Thermo Fisher Scientific and PVA Consulting Group. The Compensation Committee set his annual base salary at $225,000 and awarded 5,000 stock options with a strike price equal to the closing price on August 13, 2025; vesting will follow a schedule determined by the Committee tied to performance and retention. He is eligible for an annual performance bonus equal to 25% of base salary ($56,250), which is doubled if gross margin targets are met, with potential additional bonuses for outperformance. The filing states there are no related-party transactions or family relationships requiring disclosure.